YSK1 Activators comprises a group of compounds and molecules that have the capacity to modulate the activity of the YSK1 (serine/threonine kinase 25) protein. YSK1, also referred to as STK25, is a serine/threonine kinase enzyme that plays a pivotal role in regulating various cellular processes associated with metabolism and energy homeostasis. YSK1 has gained significant attention in the realm of cellular and metabolic research, particularly due to its involvement in insulin sensitivity, glucose metabolism, and the intricate web of signaling pathways that orchestrate metabolic homeostasis.
Chemicals falling under the category of YSK1 Activators exhibit the ability to either directly or indirectly influence YSK1's activity. They may do so through multiple mechanisms, including phosphorylation, regulation of downstream targets, or modulation of associated signaling pathways. By stimulating YSK1, these activators may play a role in shaping cellular responses to insulin, which is a key hormone in maintaining blood glucose levels and regulating metabolic processes. YSK1 Activators, therefore, hold significance in understanding the fine-tuned regulation of metabolic pathways. Their study contributes to unraveling the intricate crosstalk within cellular networks, shedding light on how cells balance energy utilization and storage. Researchers in this field aim to elucidate the precise mechanisms through which these activators impact YSK1, leading to a deeper comprehension of metabolic regulation and avenues for further exploration in metabolic research.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
A hormone that directly activates YSK1/STK25 by spurring the insulin signaling pathway, triggering its activity, and promoting cellular glucose uptake. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
A compound that indirectly activates YSK1/STK25 by stimulating AMP-activated protein kinase (AMPK), igniting YSK1/STK25's activity through energy balance regulation. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
An AMPK activator that indirectly activates YSK1/STK25 by propelling AMPK activation, resulting in the ignition of YSK1/STK25's function in metabolic pathways. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPARγ agonist that indirectly activates YSK1/STK25 by enhancing insulin sensitivity, potentially leading to YSK1/STK25 activation in insulin signaling pathways. | ||||||
Exendin-4 | 141758-74-9 | sc-474611 sc-474611A | 500 µg 1 mg | $146.00 $198.00 | 1 | |
A GLP-1 receptor agonist that indirectly stirs YSK1/STK25 by amplifying insulin sensitivity and modulating metabolic pathways that may activate YSK1/STK25. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
An SIRT1 activator that may indirectly activate YSK1/STK25 by enhancing metabolic regulation through SIRT1-mediated pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An activator that indirectly activates YSK1/STK25 by elevating cAMP levels, which can stimulate YSK1/STK25 via cAMP-related pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that indirectly stimulates YSK1/STK25 by modulating cellular signaling through elevated cAMP levels, potentially resulting in its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A Ca2+ ionophore that indirectly activates YSK1/STK25 by raising intracellular calcium levels, which may activate YSK1/STK25 indirectly through calcium-related signaling and its effects on metabolic pathways. | ||||||